IBDEI06Y ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,2738,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2738,1,3,0)
 ;;=3^Herpes, varicella
 ;;^UTILITY(U,$J,358.3,2738,1,4,0)
 ;;=4^B01.9
 ;;^UTILITY(U,$J,358.3,2738,2)
 ;;=^5000487
 ;;^UTILITY(U,$J,358.3,2739,0)
 ;;=B00.3^^7^83^107
 ;;^UTILITY(U,$J,358.3,2739,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2739,1,3,0)
 ;;=3^Herpes, Meningitis
 ;;^UTILITY(U,$J,358.3,2739,1,4,0)
 ;;=4^B00.3
 ;;^UTILITY(U,$J,358.3,2739,2)
 ;;=^5000470
 ;;^UTILITY(U,$J,358.3,2740,0)
 ;;=B00.9^^7^83^104
 ;;^UTILITY(U,$J,358.3,2740,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2740,1,3,0)
 ;;=3^Herpes NEC
 ;;^UTILITY(U,$J,358.3,2740,1,4,0)
 ;;=4^B00.9
 ;;^UTILITY(U,$J,358.3,2740,2)
 ;;=^5000480
 ;;^UTILITY(U,$J,358.3,2741,0)
 ;;=B39.2^^7^83^115
 ;;^UTILITY(U,$J,358.3,2741,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2741,1,3,0)
 ;;=3^Histoplasmosis,Pulmonary
 ;;^UTILITY(U,$J,358.3,2741,1,4,0)
 ;;=4^B39.2
 ;;^UTILITY(U,$J,358.3,2741,2)
 ;;=^5000634
 ;;^UTILITY(U,$J,358.3,2742,0)
 ;;=B39.9^^7^83^113
 ;;^UTILITY(U,$J,358.3,2742,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2742,1,3,0)
 ;;=3^Histoplasmosis NEC
 ;;^UTILITY(U,$J,358.3,2742,1,4,0)
 ;;=4^B39.9
 ;;^UTILITY(U,$J,358.3,2742,2)
 ;;=^5000638
 ;;^UTILITY(U,$J,358.3,2743,0)
 ;;=Z21.^^7^83^93
 ;;^UTILITY(U,$J,358.3,2743,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2743,1,3,0)
 ;;=3^HIV + Status (Asymptomatic)
 ;;^UTILITY(U,$J,358.3,2743,1,4,0)
 ;;=4^Z21.
 ;;^UTILITY(U,$J,358.3,2743,2)
 ;;=^5062777
 ;;^UTILITY(U,$J,358.3,2744,0)
 ;;=B20.^^7^83^92
 ;;^UTILITY(U,$J,358.3,2744,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2744,1,3,0)
 ;;=3^HIV + (Symptomatic)/AIDS
 ;;^UTILITY(U,$J,358.3,2744,1,4,0)
 ;;=4^B20.
 ;;^UTILITY(U,$J,358.3,2744,2)
 ;;=^5000555
 ;;^UTILITY(U,$J,358.3,2745,0)
 ;;=A63.0^^7^83^117
 ;;^UTILITY(U,$J,358.3,2745,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2745,1,3,0)
 ;;=3^Human Papillomavirus infection
 ;;^UTILITY(U,$J,358.3,2745,1,4,0)
 ;;=4^A63.0
 ;;^UTILITY(U,$J,358.3,2745,2)
 ;;=^5000360
 ;;^UTILITY(U,$J,358.3,2746,0)
 ;;=Z91.19^^7^83^116
 ;;^UTILITY(U,$J,358.3,2746,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2746,1,3,0)
 ;;=3^History of past non-compliance
 ;;^UTILITY(U,$J,358.3,2746,1,4,0)
 ;;=4^Z91.19
 ;;^UTILITY(U,$J,358.3,2746,2)
 ;;=^5063618
 ;;^UTILITY(U,$J,358.3,2747,0)
 ;;=T85.79XA^^7^83^118
 ;;^UTILITY(U,$J,358.3,2747,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2747,1,3,0)
 ;;=3^Infect/inflm reaction d/t implantable device graft,init encntr
 ;;^UTILITY(U,$J,358.3,2747,1,4,0)
 ;;=4^T85.79XA
 ;;^UTILITY(U,$J,358.3,2747,2)
 ;;=^5055676
 ;;^UTILITY(U,$J,358.3,2748,0)
 ;;=J11.00^^7^83^121
 ;;^UTILITY(U,$J,358.3,2748,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2748,1,3,0)
 ;;=3^Influenza with unspecified type of pneumonia
 ;;^UTILITY(U,$J,358.3,2748,1,4,0)
 ;;=4^J11.00
 ;;^UTILITY(U,$J,358.3,2748,2)
 ;;=^5008156
 ;;^UTILITY(U,$J,358.3,2749,0)
 ;;=B82.9^^7^83^122
 ;;^UTILITY(U,$J,358.3,2749,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2749,1,3,0)
 ;;=3^Intestinal parasitosis
 ;;^UTILITY(U,$J,358.3,2749,1,4,0)
 ;;=4^B82.9
 ;;^UTILITY(U,$J,358.3,2749,2)
 ;;=^5000798
 ;;^UTILITY(U,$J,358.3,2750,0)
 ;;=H83.09^^7^83^124
 ;;^UTILITY(U,$J,358.3,2750,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2750,1,3,0)
 ;;=3^Labyrinthitis, NOS
 ;;^UTILITY(U,$J,358.3,2750,1,4,0)
 ;;=4^H83.09
 ;;^UTILITY(U,$J,358.3,2750,2)
 ;;=^5006897
 ;;^UTILITY(U,$J,358.3,2751,0)
 ;;=H83.02^^7^83^126
 ;;^UTILITY(U,$J,358.3,2751,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2751,1,3,0)
 ;;=3^Labyrinthitis, left ear
 ;;^UTILITY(U,$J,358.3,2751,1,4,0)
 ;;=4^H83.02
 ;;^UTILITY(U,$J,358.3,2751,2)
 ;;=^5006895
 ;;
 ;;$END ROU IBDEI06Y
